基于风险的定价模型以及它们在患者获得新干细胞疗法的过程中可能发挥的作用
Klaus Hoeyer1, Anne Sofie Borsch1, Kim Bak Jensen2
1Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Regenerative medicine
|December 18, 2024
概括
新兴的定价模式对于使患者能够获得干细胞疗法至关重要. 本评论探讨了转化干细胞研究的经济策略和伦理考虑.
科学领域:
- 再生医学是一种再生医学.
- 卫生经济学 卫生经济学
- 生物伦理学生物伦理学
背景情况:
- 干细胞研究正在转向临床应用和患者翻译.
- 确保干细胞治疗的经济可行性对于患者的获取至关重要.
- 当前的医疗保健系统在覆盖先进疗法方面可能面临挑战.
研究的目的:
- 探索干细胞治疗的创新定价模式.
- 讨论与这些模型相关的实际和伦理挑战.
- 促进转化干细胞研究的积极规划.
主要方法:
- 对新兴经济战略的评论和分析.
- 审查实际实施的挑战.
- 价格和访问的伦理考虑.
主要成果:
- 确定先进疗法的潜在定价模型.
- 讨论成本,访问和道德标准之间的相互作用.
- 强调在干细胞商业化方面需要前性思维.
结论:
- 新型定价策略对于干细胞疗法的成功转化至关重要.
- 积极解决经济和道德问题对于公平的患者接入至关重要.
- 这项工作旨在指导该领域在应对干细胞商业化的复杂性.
更多相关视频
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Stem Cell Culture
5.1K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.1K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K


